ÂÜÀòÂÒÂ×

SJ Lee is the CEO of Orum Therapeutics, where they have raised over $120M USD in funding and built a multinational team focusing on tumor-specific targeted protein degraders. They are also an adjunct professor at Yonsei University and a member of Launchpad Venture Group. Prior to their current roles, they held various leadership positions at Sanofi and LG Life Sciences, with experience in R&D strategic planning and computational modeling. SJ Lee holds a Ph.D. in Biophysics from the University of California, Berkeley, and a BS in Biochemistry from Yonsei University.